Inventor · disambiguated record
In Jong Kim
Also filed as: KIM IN JONG
48 granted patents·13 pending applications·370 citations·filing 1995–2025
98Inventor score
Files withENANTA PHARM INC45KIM IN JONG4SLOAN KETTERING INST CANCER4OR YAT SUN2HOLSINGER LESLIE JEAN1
Top patents by PatentIndex Score
61 records- 0198US10865215B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Dec 15, 2020·16 cites·13 claims
- 0298US10358441B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2018·Granted Jul 23, 2019·27 cites·18 claims
- 0398US8575119B22′-chloroacetylenyl substituted nucleoside derivativesWANG GUOQIANG·Filed 2012·Granted Nov 5, 2013·75 cites·22 claims
- 0497US11390631B1Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Jul 19, 2022·4 cites·10 claims
- 0597US9957281B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2016·Granted May 1, 2018·32 cites·18 claims
- 0697US9085599B22′allene-substituted nucleoside derivativesOR YAT SUN·Filed 2012·Granted Jul 21, 2015·45 cites·21 claims
- 0796US11505558B1Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2021·Granted Nov 22, 2022·8 cites·21 claims
- 0895US11912695B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·5 cites·20 claims
- 0995US11572367B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2020·Granted Feb 7, 2023·9 cites·21 claims
- 1095US11254664B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Feb 22, 2022·7 cites·19 claims
- 1195US10398706B2Heteroaryldiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 3, 2019·26 cites·11 claims
- 1294US12006326B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Jun 11, 2024·3 cites·18 claims
- 1394US11945830B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Granted Apr 2, 2024·3 cites·18 claims
- 1489US12297209B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 1589US12162857B2Antiviral compoundsENANTA PHARM INC·Filed 2023·Granted Dec 10, 2024·1 cites·15 claims
- 1689US10570153B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Feb 25, 2020·4 cites·34 claims
- 1782US11952389B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2022·Granted Apr 9, 2024·0 cites·9 claims
- 1882US6544952B1Synthesis of glycoconjugates of the globo-H epitope and uses thereofSLOAN KETTERING INST CANCER·Filed 1998·Granted Apr 8, 2003·43 cites·11 claims
- 1982US2025326768A1Benzodiazepine Derivatives as RSV InhibitorsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 2081US12509470B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2024·Granted Dec 30, 2025·0 cites·8 claims
- 2180US8623814B2Antiviral agentsOR YAT SUN·Filed 2011·Granted Jan 7, 2014·5 cites·13 claims
- 2278US9221878B2Cyclosporin analogues for preventing or treating hepatitis C infectionENANTA PHARM INC·Filed 2014·Granted Dec 29, 2015·3 cites·15 claims
- 2378US8921573B2Processes for the preparation of novel benzimidazole derivativesENANTA PHARM INC·Filed 2014·Granted Dec 30, 2014·2 cites·15 claims
- 2478US2024360117A1Benzodiazepine derivatives as rsv inhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 2577US8906853B2[N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infectionENANTA PHARM INC·Filed 2013·Granted Dec 9, 2014·2 cites·12 claims
- 2677US8106059B2Substituted pyrazines that inhibit protease cathepsin S and HCV replicationHOLSINGER LESLIE JEAN·Filed 2008·Granted Jan 31, 2012·4 cites·15 claims
- 2776US8354383B26,11-bridged biaryl macrolidesENANTA PHARM INC·Filed 2009·Granted Jan 15, 2013·1 cites·34 claims
- 2874US12358921B2Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2023·Granted Jul 15, 2025·0 cites·16 claims
- 2974US6090789ASynthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereofSLOAN KETTERING INST CANCER·Filed 1997·Granted Jul 18, 2000·20 cites·13 claims
- 3071US9669095B2Cyclosporin analogues for preventing or treating hepatitis C infectionENANTA PHARM INC·Filed 2015·Granted Jun 6, 2017·1 cites·12 claims
- 3169US2025368659A1Antiviral Heterocyclic CompoundsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 3268US8273720B26,11-bicyclolides: bridged biaryl macrolide derivativesKIM IN JONG·Filed 2009·Granted Sep 25, 2012·1 cites·32 claims
- 3366US10906895B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2019·Granted Feb 2, 2021·0 cites·17 claims
- 3466US2024368174A1Antiviral Heterocyclic CompoundsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 3565US12268694B2Combination pharmaceutical agents as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Apr 8, 2025·0 cites·4 claims
- 3661US9242974B2Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivativesENANTA PHARM INC·Filed 2013·Granted Jan 26, 2016·0 cites·11 claims
- 3761US8552162B2Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivativesXU GUOYOU·Filed 2009·Granted Oct 8, 2013·0 cites·23 claims
- 3860US11945824B2Heterocyclic compounds as anti-viral agentsENANTA PHARM INC·Filed 2021·Granted Apr 2, 2024·0 cites·21 claims
- 3959US11534439B2Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2021·Granted Dec 27, 2022·0 cites·21 claims
- 4059US10759816B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 1, 2020·0 cites·20 claims
- 4159US5708163ASynthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereofSLOAN KETTERING INST CANCER·Filed 1995·Granted Jan 13, 1998·10 cites·7 claims
- 4259US2014187780A16,11-bridged biaryl macrolidesENANTA PHARM INC·Filed 2013·Application pending·0 cites
- 4357US2023115580A1Antiviral heterocyclic compoundsENANTA PHARM INC·Filed 2022·Application pending·0 cites
- 4456US2013165641A16,11-bridged biaryl macrolidesENANTA PHARM INC·Filed 2012·Application pending·0 cites
- 4555US2017226129A1Heterocyclic compounds as rsv inhibitorsENANTA PHARM INC·Filed 2017·Application pending·0 cites
- 4654US10881666B2Combination pharmaceutical agents as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Jan 5, 2021·0 cites·20 claims
- 4754US2009075915A16,11-bicyclolides: bridged biaryl macrolide derivativesKIM IN JONG·Filed 2008·Application pending·0 cites
- 4853US11179400B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Nov 23, 2021·0 cites·19 claims
- 4953US2009118506A16,11-bridged biaryl macrolidesKIM IN JONG·Filed 2008·Application pending·0 cites
- 5052US6238668B1Colon cancer KH-1 and N3 antigensSLOAN KETTERING INST CANCER·Filed 1998·Granted May 29, 2001·13 cites·12 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when In Jong Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →